Torsten Bohn is a nutritionist and food chemist by training. He works in close collaboration with internal partners (e.g. CIEC) and external collaborators (e.g. networks such as EU-COST actions) and strives to study especially the relation of micronutrient/secondary plant compound (including fiber) intake, their digestion and bioavailability, to markers of health and disease such as inflammation and oxidative stress, also looking for novel biomarkers (e.g. via proteomics, genomics). Toward this end, Torsten Bohn is involved in conducting and evaluating both human observational studies such as the ORISCAV-LUX studies, and dietary intervention trials. An additional aspect is the interaction between a healthy diet and environmental pollutants, which is studied together with internal collaborators. On top of research, training interns, Master and PhD students is also an important task, in addition to lecturing at the University of Luxembourg. Torsten Bohn also hosts the International Journal for Vitamin and Nutrition Research.
• Micronutrients and phytochemicals
• Inflammation and oxidative stress
• Digestion and metabolism
• Relation of dietary patterns and cardiometabolic health
• Diet in the context of other life-style factors such as socio-economic aspects & environment
• Editor-in-Chief International Journal for Vitamin and Nutrition Research
• Adjunct Associate Professor University of Luxembourg
• Fate of β-carotene within loaded delivery systems in food: State of knowledge.
March 10, 2021
2021 Mar. Antioxidants.10(3):426.
By: Maurya VK, Shakya A, Aggarwal M, Gothandam KM, Bohn T, Pareek S.
• Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes?
March 09, 2021
2021 Mar. Antioxidants.10(3):414.
By: Menzel A, Samouda H, Dohet F, Loap S, Ellulu MS, Bohn T.
• Behavioral manipulation-key to the successful global spread of the new coronavirus SARS‐CoV‐2?
March 01, 2021
2021 Mar. J Med Virol.93(3):1748-1751. Epub 2020 Sep 29.
By: Bouayed J, Bohn T.
• Recent progress in discovering the role of carotenoids and metabolites in prostatic physiology and pathology—A review—Part II: Carotenoids in the human studies.
February 20, 2021
2021 Feb. Antioxidants.10(2):319.
By: Dulinska-Litewka J, Halubiec P, Lazarczyk A, Szafranski O, Sharoni Y, McCubrey JA, Gasiorkiewicz B, Bohn T.
• Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?
February 16, 2021
2021 Feb. Front Mol Biosci.7:596141.
By: Trocme C, Gonnet N, Di Tommaso M, Samouda H, Cracowski JL, Cracowski C, Lambert-Porcheron S, Laville M, Nobecourt E, Gaddhab C, Le Lay A, Bohn T, Poitou C, Clement K, Al-Mulla F, Bitar MS, Bottari SP.
• Obesity considerations during the COVID-19 outbreak.
January 27, 2021
2021 Jan. Int J Vitam Nutr Res.1-13. Online ahead of print.
By: Dohet F, Loap S, Menzel A, Iddir M, Dadoun F, Bohn T, Samouda H.
• Adapted sickness behavior - why it is not enough to limit the COVID-19 spread?
January 04, 2021
2021 Jan. Brain Behav Immun. Online ahead of print.
By: Bouayed J, Bohn T.
“Micronutrients and secondary plant compounds
do influence us in many ways. While micronutrients
are truly essential for bodily functions, many
secondaryplant compounds have been associated
in epidemiological studies with health benefits.
However, their mechanism of action is still discussed,
and could include direct anti-oxidant effects,
but also and especially activity on the cellular level via transcription
factors and nuclear factors. Last but not least, many of these compounds
do interact with the microbiota, which may result in additional
health benefits”, explains Torsten Bohn, PhD, Group Leader of NutriHealth.
1A-B, rue Thomas Edison
Phone : +352 26 970 394
Fax: +352- 26 970 719